Abstract:Background: Pneumoconiosis is a group of occupational lung diseases caused by the inhalation of mineral dust in the lungs, leading to lung dysfunction. Patients with pneumoconiosis are usually accompanied by weight loss, which suggests a lipid metabolism disorder. Recent progress in lipidomics uncovered detailed lipid profiles that play important roles in respiratory diseases, such as asthma, lung cancer and lung injury. The purpose of this study was to shed light on the different expression of lipidome between pneumoconiosis and healthy, hoping to bring new ideas for the diagnosis and treatment of pneumoconiosis. Methodology: This non-matching case-control study was performed among 96 subjects (48 outpatients with male pneumoconiosis and 48 healthy volunteers), data of clinical phenotypes were recorded, and plasma biochemistry (lipidomic profiles) was tested for both pneumoconiosis patients and healthy controls. A total of 426 species in 11 lipid classes were analyzed by high-performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (HPLC-QqQ-MS) for the cases and controls. We also analyzed the correlation of lipid profiles with clinical phenomes from pneumoconiosis patients by expression quantitative trait locus (eQTL) model to evaluate trans-nodules between lipidomic profiles and clinical phenomes. All visually re-checked data were analyzed using appropriate statistical tools (t-test or one-way ANOVA test) on SPSS. Results: Compared with healthy people, 26 significantly increased (> 1.5-fold) and 30 decreased lipid elements (< 2/threefold) in patients with pneumoconiosis were identified (P values all < 0.05). The majority of those elevated lipid elements were phosphatidylethanolamines (PEs), and the minority were free fatty acids (FFAs), while phosphatidylcholines (PCs) and lysophosphatidylcholines (lysoPCs) declined in pneumoconiosis. Clinical trans-omics analyses demonstrated that phenomes in pneumoconiosis connections with multiple lipids, which showed that pH, lung function, mediastinal lymph node calcification, and complication were highly correlated with lipid elements. Furthermore, up-regulated PE was corresponded to pH, smoking history and mediastinal lymph node calcification. PC was corresponded to dust exposure history, BMI and mediastinal lymph node calcification. Conclusion: We found altered lipid panels between male pneumoconiosis patients and healthy people by qualitatively and quantitatively measured plasma lipidomic profiles. The trans-omic analysis between clinical phenomes and lipidomes might have the potential to uncover the heterogeneity of lipid metabolism of pneumoconiosis patients and to screen out clinically significant phenome-based lipid panels.

Exploration study on serum metabolic profiles of Chinese male patients with artificial stone silicosis, silicosis, and coal worker's pneumoconiosis

Serum metabolic profiling of coal worker’s pneumoconiosis using untargeted lipidomics

Diagnostic performance of distinct metabolic features in the plasma of patients with silicosis

An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022

Novel lipidomes profile and clinical phenotype identified in pneumoconiosis patients

Lipidomics Profiles and Lipid Metabolite Biomarkers in Serum of Coal Workers' Pneumoconiosis

Silicon, an important exposure marker in vivo in silicosis research

Screening of Serum Biomarkers of Coal Workers' Pneumoconiosis by Metabolomics Combined with Machine Learning Strategy.

A Differential Protein Study on Bronchoalveolar Lavage Fluid at Different Stages of Silicosis

Screening of Serum Biomarkers and Establishment of a Decision Tree in Silica-Exposed Populations by Surface-Enhanced Laser Desorption Ionization Time-of-fly Mass Spectrometry.

Exosomal proteomics and cytokine analysis distinguish silicosis cases from controls

Integrating routine blood biomarkers and artificial intelligence for supporting diagnosis of silicosis in engineered stone workers

CC-Chemokine Ligand 18, CXC Motif Chemokine 13, and Osteopontin as Biomarkers of Silicosis and Asbestosis: A Case-Control Study

Combined application of multiple biomarkers for early auxiliary diagnosis of silicosis

Unique Gut Microbiome and Metabolic Profiles in Chinese Workers Exposed to Dust: Insights From a Case-Control Study

Element-based Prognostics of Occupational Pneumoconiosis Using Micro-Proton-induced X-ray Emission Analysis.

The study of metabolism and metabolomics in a mouse model of silica pulmonary fibrosis based on UHPLC-QE-MS

Upregulated has-miR-4516 as a potential biomarker for early diagnosis of dust-induced pulmonary fibrosis in patients with pneumoconiosis.

Artificial stone‐associated silicosis in China: A prospective comparison with natural stone‐associated silicosis

Alterations and associations between lung microbiota and metabolite profiles in silica-induced lung injury

Differential expression profile of microRNAs in the lung tissues of coal workers with pneumoconiosis and patients with silicosis